Actylis completed the acquisition of Pharm-Rx.

Actylis, a manufacturer and supplier of critical raw materials and performance ingredients serving the life sciences, specialty chemicals, and agriscience industries, completed the acquisition of Pharm-Rx, a provider of value-added specialty ingredients for the Vitamin, Mineral, Supplement, and pharmaceutical industries. Financial terms were not disclosed. "We are thrilled to welcome Pharm-Rx into the Actylis family. This acquisition is a significant milestone in our growth strategy, allowing us to offer even greater value to our customers through an expanded portfolio and enhanced capabilities and expertise. By leveraging our combined strengths, we are poised to deliver the most innovative solutions to meet the ever-evolving needs of the markets that we serve. We are excited to welcome Mark Bostel to the Actylis leadership team and work together to drive accelerated growth for our combined nutrition and OTC business in partnership with our customers,” Scott Thomson, Actylis CEO.